Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Software
Create a narrative
Materialise
NasdaqGS:MTLS Community
1
Narratives
written by author
1
Comments
on narratives written by author
26
Fair Values set
on narratives written by author
Create a narrative
Materialise
Popular
Undervalued
Overvalued
Materialise
WA
Analyst Price Target
Consensus Narrative from 2 Analysts
Launch Of Mimics Flow And ACTech Expansion Will Advance Personalized Medicine
Key Takeaways Focus on personalized medical solutions and enhanced platforms could drive revenue growth and improve operational efficiencies and net margins. Partnerships and subscription-based software models aim to increase recurring revenue streams and improve earnings through scalable solutions.
View narrative
US$9.51
FV
2.4% undervalued
intrinsic discount
8.64%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
MTLS
Materialise
Your Fair Value
US$
Current Price
US$9.28
0.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-5m
402m
2015
2018
2021
2024
2025
2027
2030
Revenue €402.1m
Earnings €15.1m
Advanced
Set as Fair Value